Development of a novel catalytic array
Development of a novel catalytic array
批准号:
7325833
负责人:
Tauseef R. Butt
金额:
$26.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-20 至 2009-09-19
关键词:
AntibodiesAntibody FormationAutoantibodiesBasic ScienceBindingBioinformaticsBiological AssayBiological MarkersCell SurvivalClassComplexConditionDevelopmentDevicesDiabetes MellitusDiagnosisDiagnosticDiseaseEnhancement TechnologyEnzymesGeneral PopulationGenomicsGoalsHomeostasisImmobilizationMalignant NeoplasmsMethodsNumbersParkinsonian DisordersPathway interactionsPhasePlayProtein MicrochipsProteinsPurposeReagentRelative (related person)Research PersonnelRoleSamplingScreening procedureSerumSolidStagingStandards of Weights and MeasuresSystemTherapeuticUbiquitinUbiquitin Like ProteinsValidationVariantcostcost effectiveenzyme activityhigh throughput screeninginhibitor/antagonistinterestnoveloutcome forecastprognosticprotein expressiontherapeutic targettoolubiquitin isopeptidase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bioinformatics tools will be generated for a class of ~ 100 proteins known as de- ubiquitinating enzymes (DUBs), which play an important role in cell survival, proliferation, and differentiation. LifeSensor's proprietary SUMO expression enhancement technology permits expression and purification of DUBs with relative ease, and a high throughput microarray of these proteins will afford rapid and cost effective screening. Thus, it is proposed to develop a DUB microarray for the purpose of basic research, biomarker discovery, diagnostics/prognostics, and therapeutics. The DUB microarray will have obvious utility in biomarker discovery and diagnostics development. Expression of DUBs has been associated with diseases such as cancer, diabetes, and Parkinsonism. Over- or under-expression of proteins in disease states tend to elicit elevated or diminished auto-antibody production against those proteins. Thus, auto-antibody profiling can assist in identifying the type and stage of a disease. When a biomarker is identified, it can be further studied for its role in the diagnosis and prognosis of the disease. The particular biomarker could also be a therapeutic target. A DUB microarry not only allows one to perform high throughput screening of samples, but also to evaluate expression levels of DUBs in samples under identical conditions to correlate their effect on each other's expression levels under different circumstances. In the first aim, 10 (ten) DUBs will be immobilized on a variety of solid supports to determine the optimum support in terms of retention of enzyme activity. Next, the catalytic function of the retained DUBs will be compared with their function in a standard assay system. Finally, 50 (fifty) serum samples from the general population will be profiled for variation in the expression of autoantibodies against the DUBs. In Phase II, arrays will be built consisting of all known DUBS for ubiquitin and relevant ubiquitin-like proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of chain selective polyubiquitin markers as early detectors of Parkinson’s and Alzheimer’s Disease
-
批准号:9406658
-
项目类别:
-
资助金额:$19.03万
-
财政年份:2017
-
负责人:Tauseef R. Butt
-
依托单位:
Ubiquitin Proteasome System and Molecular Signatures of Alzheimer's Disease
-
批准号:10002167
-
项目类别:
-
资助金额:$78.53万
-
财政年份:2017
-
负责人:Tauseef R. Butt
-
依托单位:
Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease
-
批准号:9789790
-
项目类别:
-
资助金额:$77.97万
-
财政年份:2016
-
负责人:Tauseef R. Butt
-
依托单位:
A novel fluorescent assay for ubiquitin isopeptide bond cleavage
-
批准号:7909624
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2010
-
负责人:Tauseef R. Butt
-
依托单位:
Development of a Novel Method to Enhance Therapeutic Protein Production
-
批准号:7481997
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2008
-
负责人:Tauseef R. Butt
-
依托单位:
Novel assay for ubiquitin pathway enzymes as biomarkers
-
批准号:7480799
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2008
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO Fusions to Enhance Expression and Secretion of Protiens
-
批准号:7053070
-
项目类别:
-
资助金额:$53.11万
-
财政年份:2006
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO Fusions to Enhance Expression and Secretion of Protiens
-
批准号:7192506
-
项目类别:
-
资助金额:$56.32万
-
财政年份:2006
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO Fusions to Enhance Expression of Membrane Proteins
-
批准号:7555633
-
项目类别:
-
资助金额:$58.98万
-
财政年份:2005
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO Fusions to Enhance Expression of Membrane Proteins
-
批准号:7405075
-
项目类别:
-
资助金额:$59.08万
-
财政年份:2005
-
负责人:Tauseef R. Butt
-
依托单位:
A Fusion System to Prolong Plasma Half-Life of Proteins
-
批准号:6833622
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2004
-
负责人:Tauseef R. Butt
-
依托单位:
A Fusion System to Prolong Plasma Half-Life of Proteins
-
批准号:6913492
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2004
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO fusion for genome-wide protein analysis
-
批准号:6993247
-
项目类别:
-
资助金额:$61.68万
-
财政年份:2003
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO Fusions to Enhance Protein Expression & Secretion
-
批准号:6652336
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2003
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO Fusions to Enhance Protein Expression & Secretion
-
批准号:6892291
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2003
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO fusion for genome-wide protein analysis
-
批准号:7118758
-
项目类别:
-
资助金额:$60.5万
-
财政年份:2003
-
负责人:Tauseef R. Butt
-
依托单位:
SUMO Fusion For Genome Wide Protein Analysis
-
批准号:6582052
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2003
-
负责人:Tauseef R. Butt
-
依托单位:
Multivalent Antigen Expression and Vaccine for Malaria
-
批准号:6484265
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2002
-
负责人:Tauseef R. Butt
-
依托单位:
Multivalent Antigen Expression and Vaccine for Malaria
-
批准号:6626013
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2002
-
负责人:Tauseef R. Butt
-
依托单位:
Secretion of Ubiquitin-fusion Proteins
-
批准号:6528207
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2001
-
负责人:Tauseef R. Butt
-
依托单位:
海外基金